Acro Biomedical Co., Ltd. (ACBM): R&D Expense
$0
Year ended 2024-12-31
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $0 | -100.0% | 2025-07-24, From 2024-01-01 |
| 2023-12-31 | $4.79M | -52.4% | 2025-07-24, From 2023-01-01 |
| 2022-12-31 | $10.08M | +90.7% | 2025-07-18, From 2022-01-01 |
| 2021-12-31 | $5.29M | n/a | 2023-07-21, From 2021-01-01 |